ALLR:NASDAQ, Allarity Therapeutics, Inc.

ALLR stock overview

Allarity Therapeutics, Inc. (ALLR:NASDAQ) closed at $0.785 on November 20, 2026, down 9.25% on the day. The stock trades 57.3% below its 52-week high of $1.84 and 2.1% above its 52-week low of $0.769. Over the past year, it lost 32.9%. Allarity Therapeutics, Inc. is part of the Health Care sector.

Key figures

Price
$0.785
Day change
-9.25%
Volume
305,151
Average volume
128,714
Market cap
12M+
52-week range
$0.769 – $1.84
50-day average
$0.979
200-day average
$1.21

Price action over the past year

In 252 trading sessions since November 20, 2025, ALLR closed higher on 111 days (44%). Its best day was March 6, 2026 (+21.57%) and its worst was October 12, 2026 (-13.13%). The stock moved 10% or more in a single session 14 times.

Recent signals

ALLR news

About Allarity Therapeutics, Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improve clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra.

Similar stocks

Find more stocks like ALLR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.